The investigational compounds; novel phthalazine derivatives for cancer targeting vegfr kinase inhibitors

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: KIM, Chae Won (Duksung Women's University, College of Pharmacy, Seoul, Korea, Republic Of)
  • Co-author(s): Chae Won Kim: College of Pharmacy, Duksung Women's University, Seoul, Korea, Republic Of
    Myung-Sook Park: College of Pharmacy, Duksung Women's University, Seoul, Korea, Republic Of
  • Abstract:

    Background

    "EN-US">According to the reported data of National Cancer Information Center in 2015, South Koreans have been troubled with cancer since 1999, amounting to a total of approximately 1.46 million. Therefore, for a long time, many global pharmaceutical companies have been trying to develop cancer drugs. Vatalanib, which received FDA

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login